NovaBay Pharmaceuticals, Inc. (NBY)
After hours:
Chart Events
Performance Outlook
| Previous Close | 0.2809 |
| Open | 0.2800 |
| Bid | 0.3102 x 1100 |
| Ask | 0.3200 x 900 |
| Day's Range | 0.2801 - 0.3610 |
| 52 Week Range | 0.1700 - 0.7700 |
| Volume | |
| Avg. Volume | 668,267 |
| Market Cap | 17.99M |
| Beta (5Y Monthly) | 2.81 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.1130 |
| Earnings Date | Aug 11, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3.10 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for NBY
Related Research
- NovaBay Pharmaceuticals, Inc.Analyst Report: Pfizer Inc.Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 vaccine sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor.RatingFair ValueEconomic Moat7 days agoMorningstar
- Business Wire
NovaBay Pharmaceuticals to Hold Second Quarter 2022 Conference Call on August 11
EMERYVILLE, Calif., August 04, 2022--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three and six months ended June 30, 2022 after market close on Thursday, August 11, 2022 and will hold an investment community conference call that day beginning at 4:30 p.m. Eastern time.
- Business Wire
NovaBay Pharmaceuticals Targets New Market with Antimicrobial Avenova® Lid and Lash Spray for Lash Extensions
EMERYVILLE, Calif., July 28, 2022--NovaBay Pharmaceuticals targets the lash extension market with antimicrobial Avenova lid and lash spray.
- Business Wire
NovaBay Pharmaceuticals’ DERMAdoctor Products Now Available at Target.com and Urbanoutfitters.com
EMERYVILLE, Calif., July 21, 2022--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a pharmaceutical company developing and commercializing high-quality, scientifically formulated eyecare and skincare products, announces the availability of select DERMAdoctor products at two popular U.S. online retailers, Target.com and Urbanoutfitters.com.
